Cargando…
Plasticity and mTOR: Towards Restoration of Impaired Synaptic Plasticity in mTOR-Related Neurogenetic Disorders
Objective. To review the recent literature on the clinical features, genetic mutations, neurobiology associated with dysregulation of mTOR (mammalian target of rapamycin), and clinical trials for tuberous sclerosis complex (TSC), neurofibromatosis-1 (NF1) and fragile X syndrome (FXS), and phosphatas...
Autores principales: | Gipson, Tanjala T., Johnston, Michael V. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3350854/ https://www.ncbi.nlm.nih.gov/pubmed/22619737 http://dx.doi.org/10.1155/2012/486402 |
Ejemplares similares
-
Dysregulation of the mTOR Pathway Mediates Impairment of Synaptic Plasticity in a Mouse Model of Alzheimer's Disease
por: Ma, Tao, et al.
Publicado: (2010) -
PLPPR4 haploinsufficiency causes neurodevelopmental disorders by disrupting synaptic plasticity via mTOR signalling
por: Li, Huanzheng, et al.
Publicado: (2023) -
Neuronal mTOR Outposts: Implications for Translation, Signaling, and Plasticity
por: Altas, Bekir, et al.
Publicado: (2022) -
The mTOR signaling pathway regulates pain-related synaptic plasticity in rat entorhinal-hippocampal pathways
por: Lyu, Dan, et al.
Publicado: (2013) -
mTOR Pathway and mTOR Inhibitors in Head and Neck Cancer
por: Gao, Wei, et al.
Publicado: (2012)